Jeff Mann serves as the Senior Vice President, General Counsel, and Product Development at EMBECTA CORP, a leading medical device company focused on diabetes care. In his role, Mann is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory standards, and driving the development of innovative products that meet the needs of diabetic patients worldwide. His dual focus on legal and product development positions him as a key strategic leader within the organization. Before joining EMBECTA CORP, Mann built an impressive career in the legal and healthcare industries. He holds a Juris Doctor degree from a top-tier law school and has over two decades of experience in corporate law, with a specialization in the medical device sector. Prior to his current position, Mann served as General Counsel at a prominent medical technology firm, where he played a crucial role in navigating complex legal landscapes and facilitating the company's growth. His expertise in intellectual property, regulatory compliance, and product development has been instrumental in driving EMBECTA CORP's success. Under Mann's leadership, EMBECTA CORP has seen significant advancements in its product portfolio, particularly in the development of cutting-edge insulin delivery systems. His strategic vision and collaborative approach have fostered a culture of innovation within the company, enabling EMBECTA CORP to stay at the forefront of the diabetes care industry. Mann's dedication to improving patient outcomes and his ability to balance legal and product development responsibilities have made him an invaluable asset to EMBECTA CORP and the broader healthcare community.